Safety and ef fi cacy of p38 mitogen-activated protein kinase inhibitors (mapkis) in copd

HIGHLIGHTS

SUMMARY

    Chronic inflammation is the core mechanism of the development of chronic obstructive pulmonary disease (COPD). Three types of data, including basic information of included studies, pre-defined outcome data, and quality assessment information were extracted. Corticosteroid resistance (Chung, 2011). p38 MAPK overexpression has also been found in lung tissue and correlated with poorer lung function in the COPD population (Renda et_al, 2008; Gaffey et_al, 2013). In the rat model, p38 MAPKIs showed a promising effect on inhibiting airway inflammation (Escott et_al, 2000; Duan et_al, 2005). A hypothesis emerged that p38 MAPKIs might slow down . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?